Standardize the diagnosis and treatment of drug-induced liver injury, and strengthen clinical and translational research / 中华肝脏病杂志
Chinese Journal of Hepatology
;
(12): 337-338, 2023.
Article
in Chinese
| WPRIM
| ID: wpr-986138
ABSTRACT
As a liver disease with the most complex clinical phenotype, drug-induced liver injury (DILI) poses great challenges in diagnosis and management in clinical practice. Although guidelines based on the latest research advances can provide clinicians with guidance on the identification, diagnosis, and management of DILI, the overall level of evidence in this field is relatively low and high-level evidence is limited. Therefore, we should interpret guidelines with caution and look forward to more clinical and translational research to address the huge unmet clinical needs in DILI.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Chemical and Drug Induced Liver Injury
/
Translational Research, Biomedical
/
Liver Diseases
/
Liver Function Tests
Limits:
Humans
Language:
Chinese
Journal:
Chinese Journal of Hepatology
Year:
2023
Type:
Article
Similar
MEDLINE
...
LILACS
LIS